Tsinghua AIR and Shuimu Molecular Open-Source OpenBioMed, Redefining AI in Pharma

The Institute for Intelligent Industrial Research (AIR) at Tsinghua University, in collaboration with Shuimu Molecular, has launched and open-sourced OpenBioMed Skills—a suite of large language model plugins for biomedical research. This pioneering project translates expert biomedical decision-making processes into executable Agent Skill code and is publicly available on GitHub. The initial release features 45 core skills spanning five critical domains: biochemistry and drug development, protein analysis and design, single-cell omics analysis, and data retrieval tool integration. It aims to overcome engineering barriers across the entire biomedical R&D pipeline.
By deploying OpenBioMed Skills on its namesake open-source platform, researchers can directly access specialized multimodal models such as PharMolixFM, BioMedGPT-R1, and MutaPLM. Compared to general-purpose large language models like ChatGPT, this system shows marked advantages in comprehending domain-specific knowledge and executing pharmaceutical research logic. It also supports remote management of biomedical Agents via mobile applications including Feishu, DingTalk, and WeChat.
Nie Zaiqing, Chief Researcher at Tsinghua University and Chief Scientist at Shuimu Molecular, noted that this initiative represents a shift in drug development—from reliance on expert intuition toward intelligent, collaborative innovation. In the era of AI for Science, OpenBioMed Skills enables natural language to drive complex pharmaceutical workflows through systematic, coded processes. This provides robust infrastructure for advancing next-generation drug discovery paradigms.
Related article
Hangzhou Shangcheng District Launches Zhejiang's First AIGC Audio-Visual 'Golden Ten Measures', 5 Billion Industry Fund
On the 16th, the AIGC Audio-Visual Industry Innovation Ecosystem Conference took place in Hangzhou's Shangcheng District. During the event, the province unveiled its first dedicated policy for the AIGC audio-visual industry—"The Golden Ten." This pol
MIIT Seeks Public Feedback on 121 Industry Standards, Including AI Model Context Protocol
China's Ministry of Industry and Information Technology has officially released a notice seeking public feedback on 121 industry standardization projects, including the "Application Security Requirements for the Artificial Intelligence Security Gover
OpenAI Partners with U.S. Department of Defense, ChatGPT Uninstallations Surge 295%
Public Outrage: OpenAI's Military Partnership Sparks a 'Uninstall Surge'Recently, AI leader OpenAI announced a deep partnership with the U.S. Department of Defense (DoD), integrating its AI models into top-secret military networks. The news sparked w
Related Special Topic Recommendations
Comments (0)
0/500

The Institute for Intelligent Industrial Research (AIR) at Tsinghua University, in collaboration with Shuimu Molecular, has launched and open-sourced OpenBioMed Skills—a suite of large language model plugins for biomedical research. This pioneering project translates expert biomedical decision-making processes into executable Agent Skill code and is publicly available on GitHub. The initial release features 45 core skills spanning five critical domains: biochemistry and drug development, protein analysis and design, single-cell omics analysis, and data retrieval tool integration. It aims to overcome engineering barriers across the entire biomedical R&D pipeline.
By deploying OpenBioMed Skills on its namesake open-source platform, researchers can directly access specialized multimodal models such as PharMolixFM, BioMedGPT-R1, and MutaPLM. Compared to general-purpose large language models like ChatGPT, this system shows marked advantages in comprehending domain-specific knowledge and executing pharmaceutical research logic. It also supports remote management of biomedical Agents via mobile applications including Feishu, DingTalk, and WeChat.
Nie Zaiqing, Chief Researcher at Tsinghua University and Chief Scientist at Shuimu Molecular, noted that this initiative represents a shift in drug development—from reliance on expert intuition toward intelligent, collaborative innovation. In the era of AI for Science, OpenBioMed Skills enables natural language to drive complex pharmaceutical workflows through systematic, coded processes. This provides robust infrastructure for advancing next-generation drug discovery paradigms.
Hangzhou Shangcheng District Launches Zhejiang's First AIGC Audio-Visual 'Golden Ten Measures', 5 Billion Industry Fund
On the 16th, the AIGC Audio-Visual Industry Innovation Ecosystem Conference took place in Hangzhou's Shangcheng District. During the event, the province unveiled its first dedicated policy for the AIGC audio-visual industry—"The Golden Ten." This pol
MIIT Seeks Public Feedback on 121 Industry Standards, Including AI Model Context Protocol
China's Ministry of Industry and Information Technology has officially released a notice seeking public feedback on 121 industry standardization projects, including the "Application Security Requirements for the Artificial Intelligence Security Gover
OpenAI Partners with U.S. Department of Defense, ChatGPT Uninstallations Surge 295%
Public Outrage: OpenAI's Military Partnership Sparks a 'Uninstall Surge'Recently, AI leader OpenAI announced a deep partnership with the U.S. Department of Defense (DoD), integrating its AI models into top-secret military networks. The news sparked w





Home






